Metagenomics Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Product and Service (Reagents & consumables, Instruments, Services), By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics), By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications), By Region, and By Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Global Metagenomics Sequencing Market has valued at USD 1.96 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 14.23% through 2028. Metagenomics Sequencing Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing awareness about genetic disorders due to genetic history along with growing demand for advanced bioinformatics tools. Also, growing development of novel drugs and high throughput screening methods along with cost effective technologies developments are expected to create lucrative growth during the forecast period. Similarly, rise in research and development activities for identifying newer antibiotics and enzymes is a major factor fueling the growth of market over the upcoming years. For instance, in August 2022, OpGen, Inc., a personalized medicine company, announced to launch next-generation sequencing (NGS) services under the subsidiary, Ares Genetics.

Growing demand for personalized medicine

Personalized medicine is a key driver for the growth of the Global Metagenomics Sequencing Market. Personalized medicine aims to provide targeted therapies and treatments that are tailored to the individual patient based on their specific genetic makeup and environmental factors. Metagenomics sequencing provides a powerful tool for understanding the composition and function of microbes which are present in our body, can be used to develop therapies for the chronic diseases. Metagenomics sequencing can be used to identify the specific microbes present in a patient's gut, skin, or other body sites, and determine how these microbes are interacting with the patient's immune system and other physiological systems. This information is generally used to develop therapies that can modulate the patient’s microbiome for treating the conditions such as cancer, diabetes, inflammatory bowel disease. In addition, metagenomics sequencing can be used to identify the specific pathogens that are causing an infectious disease, and to determine the most effective treatments for those pathogens. This can help to reduce the use of broad-spectrum antibiotics and other treatments that can lead to the development of antibiotic resistance.

Advancements in sequencing technologies

Advancements in sequencing technologies have had a significant impact on the growth of the Global Metagenomics Sequencing Market. Next-generation sequencing and single-molecule sequencing technologies have greatly enhanced the throughput, accuracy, and speed of metagenomics sequencing, making it more accessible to a wider range of users, including researchers and clinicians. These advancements have led to the development of new bioinformatics tools and software that can more effectively analyze the vast amounts of data generated by metagenomics sequencing. These tools help researchers and clinicians to extract more meaningful insights from metagenomics data, and develop new diagnostic and therapeutic applications. In addition, the development of portable sequencing technologies is enabling metagenomics sequencing to be performed in field settings, making it possible to study microbial communities in remote or resource-limited areas. This is opening new opportunities for environmental monitoring, public health, and agriculture applications. As sequencing technologies continue to advance, the cost of metagenomics sequencing is expected to continue to decline, making it more accessible to researchers and clinicians around the world. This is expected to drive the growth of the global metagenomics sequencing market, as the technology becomes more widely adopted in a range of research, clinical, and commercial applications.

Increasing need for environmental monitoring and management

Environmental monitoring and management are important drivers of the growth of the Global Metagenomics Sequencing Market. Metagenomics sequencing can be used to study microbial communities in a wide range of environments, including soil, water, air, and the built environment. This information can be used to better understand the ecology and function of these communities, and to develop more effective strategies for environmental management and remediation.

Particularly, metagenomics sequencing can be used to identify and monitor microbial indicators of environmental health, such as pathogenic bacteria, fungi, and viruses. This can be important for identifying and managing outbreaks of infectious diseases in human and animal populations, and for monitoring the health of ecosystems and natural resources. In addition, metagenomics sequencing can be used to study the impact of environmental stressors, such as pollution and climate change, on microbial communities and their functions. The growing demand for environmental monitoring and management is driving the development of new metagenomics sequencing technologies and analytical tools that are better suited to these applications.

Rising demand for precision agriculture

Precision agriculture is a key driver for the growth of the global metagenomics sequencing market. Precision agriculture is a farming technique that uses data-driven approaches to optimize crop production and reduce environmental impact. Metagenomics sequencing can be used to study the microbial communities that live in the soil and on plants, and to better understand the interactions between these communities about plant health and growth. By studying the microbial communities in the soil and on plants, farmers can gain a better understanding of the nutrient and water requirements of crops, as well as their susceptibility to pests and diseases. This information can be used to develop more targeted fertilization, irrigation, and pest management strategies, leading to increased crop yields and reduced environmental impact.

Metagenomics sequencing can also be used to study the diversity of soil microbial communities and their functional roles in soil processes such as nutrient cycling, carbon sequestration, and soil aggregation. This information can be used to develop new strategies for sustainable agriculture that promote soil health and resilience, while also reducing the use of synthetic fertilizers and pesticides. As precision agriculture continues to gain traction, the demand for metagenomics sequencing is expected to increase, driving the development of new technologies and analytical tools that are better suited to these applications. Further, expected to drive the growth of the Global Metagenomics Sequencing Market, as farmers, researchers, and agribusinesses adopt metagenomics sequencing to optimize crop production and improve sustainability.

Growing availability of funding for genomics research

Government funding for genomic research has played a critical role in the growth of the Global Metagenomics Sequencing Market. Genomic research is expensive and requires significant investment in equipment, infrastructure, and personnel. Government funding can help to provide the necessary resources to support research and development in the field of metagenomics sequencing.

Government funding has supported the development of new sequencing technologies, bioinformatics tools, and data analysis methods, which have greatly enhanced the accuracy and speed of metagenomics sequencing. This has made it possible to sequence larger and more complex samples, which has led to new insights into the diversity and function of microbial communities in a range of environments. Government funding has also supported the translation of metagenomics research into clinical and commercial applications. For example, government funding has supported the development of metagenomics-based diagnostic tests for infectious diseases and cancer, as well as the development of new drugs and therapies based on insights gained from metagenomics research.

In addition to funding research and development, government funding can help to create a favorable policy environment for the adoption of metagenomics sequencing in research and clinical settings. This can include regulations that promote the use of genomic data in medical practice and research, as well as initiatives that promote the sharing of genomic data across different research groups.

Download Free Sample Report


Recent Development

 

·    Oxford Nanopore PromethION: Oxford Nanopore launched the PromethION sequencing platform in 2018, which is a portable and scalable system for real-time sequencing of long DNA fragments. The platform can be used for a wide range of applications, including metagenomics sequencing.

·     QIAGEN Microbial Insights ARB: QIAGEN launched the Microbial Insights ARB in 2020, which is a metagenomics analysis software that enables researchers to study microbial communities and their functions in various environments. The software uses a database of annotated microbial genomes to provide accurate taxonomic and functional analysis of metagenomic data.

·    BGI One-Stop Microbiome Sequencing Service: In 2022, BGI launched its One-Stop Microbiome Sequencing Service, which is a comprehensive service for analyzing microbiome samples using metagenomics sequencing. The service includes sample preparation, sequencing, and data analysis, and is designed for a wide range of applications, including medical and environmental research.

·    PacBio Sequel IIe System: PacBio launched the Sequel IIe System in 2021, which is a high-throughput, long-read sequencing platform that can generate up to 10 terabases of data in a single run. The system is designed for a wide range of applications, including metagenomics sequencing.

·   Illumina DRAGEN Metagenomics Pipeline: In 2021, Illumina launched its DRAGEN Metagenomics Pipeline, which is a software solution for analyzing metagenomics sequencing data. The pipeline uses advanced algorithms and machine learning techniques to provide accurate taxonomic and functional analysis of microbial communities.


Market Segmentation

 

Global Metagenomics Sequencing Market can be segmented by product and service, technology, application, and by region. Based on the product and service, the market can be segmented into reagents & consumables, instruments, and services. Based on technology, the market can be segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, whole genome sequencing & de novo assembly, and meta transcriptomics. Based on application, the market can be differentiated into drug discovery, ecological & environmental metagenomics, clinical diagnostics, biofuel, and industrial applications.

 

Market Players

BGI Genomics Co Ltd., Eurofins Scientific Se., Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V., Swift Biosciences Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Metagenomics Sequencing Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

By Product and Service

By Technology

By Application

By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

BGI Genomics Co Ltd., Eurofins Scientific Se., Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V., Swift Biosciences Inc., Thermo Fisher Scientific Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Global Metagenomics Sequencing market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Metagenomics Sequencing Market, By Product and Service:
    • Reagents & consumables
    • Instruments
    • Services
  • Metagenomics Sequencing Market, By Technology:
    • Shotgun metagenomic sequencing
    • 16S rRNA sequencing
    • Whole genome sequencing & de novo assembly
    • Meta transcriptomics
  • Metagenomics Sequencing Market, By Application:
    • Drug discovery
    • Ecological & environmental metagenomics
    • Clinical diagnostics
    • Biofuel
    • Industrial applications
  • Metagenomics Sequencing Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Metagenomics Sequencing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Metagenomics Sequencing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Metagenomics Sequencing Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product and Service (Reagents & consumables, Instruments, Services)

5.2.2.     By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)

5.2.3.     By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)

5.2.4.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.5.     By Company (2022)

5.3.  Market Map

5.3.1 By Product & services

5.3.2 By Technology

5.3.3 By Application

5.3.4 By Region

6.    North America Metagenomics Sequencing Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product and Service (Reagents & consumables, Instruments, Services)

6.2.2.     By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)

6.2.3.     By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)

6.2.4.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Metagenomics Sequencing Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product & Services

6.3.1.2.2.             By Technology

6.3.1.2.3.             By Application

6.3.2.     Canada Metagenomics Sequencing Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product & Services

6.3.2.2.2.             By Technology

6.3.2.2.3.             By Application

6.3.3.     Mexico Metagenomics Sequencing Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product & Services

6.3.3.2.2.             By Technology

6.3.3.2.3.             By Application

7.    Europe Metagenomics Sequencing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product and Service (Reagents & consumables, Instruments, Services)

7.2.2.     By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)

7.2.3.     By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)

7.2.4.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Metagenomics Sequencing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product & Services

7.3.1.2.2.             By Technology

7.3.1.2.3.             By Application

7.3.2.     Germany Metagenomics Sequencing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product & Services

7.3.2.2.2.             By Technology

7.3.2.2.3.             By Application

7.3.3.     United Kingdom Metagenomics Sequencing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product & Services

7.3.3.2.2.             By Technology

7.3.3.2.3.             By Application

7.3.4.     Italy Metagenomics Sequencing Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product & Services

7.3.4.2.2.             By Technology

7.3.4.2.3.             By Application

7.3.5.     Spain Metagenomics Sequencing Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product & Services

7.3.5.2.2.             By Technology

7.3.5.2.3.             By Application

8.    Asia-Pacific Metagenomics Sequencing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product and Service (Reagents & consumables, Instruments, Services)

8.2.2.     By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)

8.2.3.     By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)

8.2.4.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Metagenomics Sequencing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product & Services

8.3.1.2.2.             By Technology

8.3.1.2.3.             By Application

8.3.2.     India Metagenomics Sequencing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product & Services

8.3.2.2.2.             By Technology

8.3.2.2.3.             By Application

8.3.3.     Japan Metagenomics Sequencing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product & Services

8.3.3.2.2.             By Technology

8.3.3.2.3.             By Application

8.3.4.     South Korea Metagenomics Sequencing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product & Services

8.3.4.2.2.             By Technology

8.3.4.2.3.             By Application

8.3.5.     Australia Metagenomics Sequencing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product & Services

8.3.5.2.2.             By Technology

8.3.5.2.3.             By Application

9.    South America Metagenomics Sequencing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product and Service (Reagents & consumables, Instruments, Services)

9.2.2.     By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)

9.2.3.     By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)

9.2.4.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Metagenomics Sequencing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product & Services

9.3.1.2.2.             By Technology

9.3.1.2.3.             By Application

9.3.2.     Argentina Metagenomics Sequencing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product & Services

9.3.2.2.2.             By Technology

9.3.2.2.3.             By Application

9.3.3.     Colombia Metagenomics Sequencing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product & Services

9.3.3.2.2.             By Technology

9.3.3.2.3.             By Application

10.  Middle East and Africa Metagenomics Sequencing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product and Service (Reagents & consumables, Instruments, Services)

10.2.2.  By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)

10.2.3.  By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)

10.2.4.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Metagenomics Sequencing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product & Services

10.3.1.2.2.           By Technology

10.3.1.2.3.           By Application

10.3.2.  Saudi Arabia Metagenomics Sequencing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product & Services

10.3.2.2.2.           By Technology

10.3.2.2.3.           By Application

10.3.3.  UAE Metagenomics Sequencing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product & Services

10.3.3.2.2.           By Technology

10.3.3.2.3.           By Application

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Development

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Global Metagenomics Sequencing Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Product Offerings

15.3.              Recent Developments

15.4.              Financials (As Reported)

15.5.              Key Personnel

15.6.              SWOT Analysis

15.6.1  BGI Genomics Co Ltd.

15.6.2  Eurofins Scientific Se.

15.6.3  Illumina Inc.

15.6.4  Macrogen Inc.

15.6.5  Oxford Nanopore Technologies Ltd.

15.6.6  Pacific Biosciences of California Inc.

15.6.7  Perkinelmer Inc.

15.6.8  Qiagen N.V.

15.6.9  Swift Biosciences Inc.

15.6.10              Thermo Fisher Scientific Inc.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increasing awareness about metagenomics is attributed to the increasing Research and development expenditure, declining expenses of sequencing, and technological advancements are some of the major factors driving the growth of the Global Metagenomics Sequencing Market.

down-arrow

BGI Genomics Co Ltd., Eurofins Scientific Se., Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V., Swift Biosciences Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Metagenomics Sequencing Market.

down-arrow

Whole genome sequencing & de novo assembly is expected to dominate the Global Metagenomics Sequencing market during the forecast period due to Increasing prevalence of genetic disorders along with growing demand for genome study of the chronic diseases across the globe.

down-arrow

North American region is expected to hold the largest share in the Global Metagenomics Sequencing Market due to the technological advancements in the Next Generation Sequencing procedures.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Metagenomics Sequencing Market to be dominated by Whole genome sequencing & de novo assembly through 2028.

May, 2023

The rise in research and development activities for development of new drugs is expected to drive the growth of Global Metagenomics Sequencing Market during the forecast period, 2024-2028.

Why Choose Us